Fresenius Medical Care AG (FMS)
21.72
+0.84
(+4.00%)
USD |
NYSE |
May 10, 16:00
21.72
0.00 (0.00%)
After-Hours: 19:14
Fresenius Medical Care Cash from Investing (Quarterly): -74.26M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -74.26M |
| December 31, 2023 | -101.71M |
| September 30, 2023 | -164.03M |
| June 30, 2023 | -148.08M |
| March 31, 2023 | -175.37M |
| December 31, 2022 | -261.30M |
| September 30, 2022 | -77.90M |
| June 30, 2022 | -198.52M |
| March 31, 2022 | -237.12M |
| December 31, 2021 | -503.43M |
| September 30, 2021 | -341.66M |
| June 30, 2021 | -300.28M |
| March 31, 2021 | -269.99M |
| December 31, 2020 | -494.77M |
| September 30, 2020 | -376.77M |
| June 30, 2020 | -308.33M |
| March 31, 2020 | -344.67M |
| December 31, 2019 | -626.22M |
| September 30, 2019 | -364.92M |
| June 30, 2019 | -396.96M |
| March 31, 2019 | -2.291B |
| December 31, 2018 | -471.38M |
| September 30, 2018 | -858.48M |
| June 30, 2018 | 1.531B |
| March 31, 2018 | -490.95M |
| Date | Value |
|---|---|
| December 31, 2017 | 65.76M |
| September 30, 2017 | -385.61M |
| June 30, 2017 | -424.92M |
| March 31, 2017 | -378.15M |
| December 31, 2016 | -451.33M |
| September 30, 2016 | -264.34M |
| June 30, 2016 | -326.03M |
| March 31, 2016 | -337.46M |
| December 31, 2015 | -250.86M |
| September 30, 2015 | -279.45M |
| June 30, 2015 | -252.97M |
| March 31, 2015 | -217.59M |
| December 31, 2014 | -1.184B |
| September 30, 2014 | -907.69M |
| June 30, 2014 | -520.21M |
| March 31, 2014 | -330.64M |
| December 31, 2013 | -399.79M |
| September 30, 2013 | -355.25M |
| June 30, 2013 | -180.51M |
| March 31, 2013 | -223.92M |
| December 31, 2012 | -274.46M |
| September 30, 2012 | -123.89M |
| June 30, 2012 | -198.91M |
| March 31, 2012 | -1.620B |
| December 31, 2011 | -909.22M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-626.22M
Minimum
Dec 2019
-74.26M
Maximum
Mar 2024
-288.31M
Average
-285.13M
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.0038M |
| TC BioPharm (Holdings) PLC | -- |
| DaVita Inc | -215.21M |
| Bicycle Therapeutics PLC | -0.012M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 138.28M |
| Cash from Financing (Quarterly) | -314.62M |
| Free Cash Flow | 2.097B |
| Free Cash Flow Per Share (Quarterly) | -0.0122 |
| Free Cash Flow to Equity (Quarterly) | 175.99M |
| Free Cash Flow to Firm (Quarterly) | 64.65M |
| Free Cash Flow Yield | 16.46% |